IPMNs with malignant characteristics, including high-grade dysplasia and invasive carcinoma, always had higher serum CEA, CA19–9 and ferritin levels than non-malignant IPMNs (p <  0.05). This evidence concerns the gene CEACAM5 and invasive carcinoma.